Back

OGN Stock

Current 11.26 USD

Trend Flat

Sentiment Neutral

OGN at a glance

11.26 USD

USD per share

Market: Pre-market
Data: Stale Finnhub (stored) · 4 months, 1 week ago

Dominant narrative

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Bloomberg · 3 months, 4 weeks ago · Article tone: Neutral · Model direction: Neutral

The potential acquisition could lead to a short-term increase in Sun Pharma's stock price, while Organon & Co.'s stock may experience volatility due to the uncertainty surrounding the deal.

Model agreement

1 open call across the models tracking this asset.

Neutral 1 · 100%

Rule-Based Analysis Neutral

Verification state

0 of 62 calls on this asset have reached a verdict (0%).

Generated 62
Awaiting evaluation 1
Verified 0
Excluded 61

How these are scored

Observed bias

Neutral

1 of 1 open model calls on OGN record no directional lean. Average recorded confidence is 30%. Most were logged against a 24h window.

Agreement: 1 of 1 open calls
Confidence: 30% What confidence means
Horizon: 24h
Invalidating condition: The reading holds while price stays inside the observed 10.70 – 11.82 USD band; a close outside it would remove its basis.

Supporting evidence

Technical reading logged by Rule-Based Analysis Rule-Based Analysis · Aug 28 09:17

A description of what the tracked models have logged. Not a recommendation, and not personalised to any reader.

Calls on this asset

How these are scored

Rule-Based Analysis not AI Neutral 30% Aug 28 09:17 · 24h

Generated 6h 24h Verified
Rule-Based Analysis not AI Neutral 30% Aug 27 06:27 · 24h

Generated 6h 24h Excluded

No price movement recorded for OGN in the 2 days after its timeframe closed; the symbol appears to have no active price feed
Rule-Based Analysis not AI Neutral 30% Aug 23 21:23 · 24h

Generated 6h 24h Excluded

Expired: not evaluated within 7 days of its 24h timeframe elapsing
Rule-Based Analysis not AI Neutral 30% Aug 22 15:01 · 24h

Generated 6h 24h Excluded

Expired: not evaluated within 7 days of its 24h timeframe elapsing
Rule-Based Analysis not AI Neutral 30% Aug 18 18:16 · 24h

Generated 6h 24h Excluded

Expired: not evaluated within 7 days of its 24h timeframe elapsing

Price Chart

📈

Loading chart for OGN...

Quick Overview

Trend → Flat

Volatility Low

Sentiment 😐 Neutral

Data Status

Stale

Finnhub (stored)

Limited history — some indicators are estimated

Detailed Market Analysis

Key Levels

Support

10.70 USD

Resistance

11.82 USD

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

Weak

Technical Context

Current price

11.26 USD

RSI context

Market Sentiment

Neutral

Stock Metrics

Daily Vol

VIX Est

Weekly

Asset Intelligence Dossier

Currency: USD
Quoted in: USD per share
Exchange: —
Timezone: America/New_York
Market: Pre-market

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 1 call in the last 7 days

What sources say

No news-sourced AI calls in the last 30 days.

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

OGN News Intelligence (2 articles)

AI-curated news influencing OGN price, sentiment, and trend

Explore All OGN News with AI Analysis

Economy

3 months, 4 weeks ago

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New …

Impact on OGN: The potential acquisition could lead to a short-term increase in Sun Pharma's …

Sun Pharma's proposed $12 billion acquisition of Organon & Co. is exploring funding options, which … Medium (60%)

View full analysis →

Bloomberg 60% confidence

Stocks

4 months, 1 week ago

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

To fuel its global ambitions, Sun Pharmaceutical Industries plans to acquire New Jersey-based Organon & Co in an all-cash deal …

Impact on OGN: The acquisition is likely to boost Sun Pharma's stock price, with potential …

Sun Pharmaceutical Industries is acquiring Organon & Co for $11.75 billion, marking a significant expansion … High (80%)

View full analysis →

CNBC 80% confidence

AI evidence

Every call logged on OGN, traced from the source that triggered it to the outcome it was scored against.

Rule-Based Analysis Awaiting evaluation Aug 28, 2026 09:17

Direction
Neutral

Confidence
30%

Reference price
11.26

Verification window
24h

Outcome

Not yet due

Evidence

Source Technical analysis pipeline

Claim Neutral reading on OGN

Affected assets OGN

AI inference Neutral · 30%

Reference price 11.26

Verification window 24h

Actual outcome Awaiting evaluation

Provenance

Provider
Rule-Based Analysis

Model version

Not recorded for this call

Methodology version

Scored before versions were recorded

Record

rule-based-analysis #291576
Rule-Based Analysis Excluded from scoring Aug 27, 2026 06:27

Direction
Neutral

Confidence
30%

Reference price
11.26

Verification window
24h

Outcome

No price movement recorded for OGN in the 2 days after its timeframe closed; the symbol appears to have no active price feed

Evidence

Source Technical analysis pipeline

Claim Neutral reading on OGN

Affected assets OGN

AI inference Neutral · 30%

Reference price 11.26

Verification window 24h

Actual outcome No price movement recorded for OGN in the 2 days after its timeframe closed; the symbol appears to have no active price feed

Provenance

Provider
Rule-Based Analysis

Model version

Not recorded for this call

Methodology version

Scored before versions were recorded

Record

rule-based-analysis #288845
Rule-Based Analysis Excluded from scoring Aug 23, 2026 21:23

Direction
Neutral

Confidence
30%

Reference price
11.26

Verification window
24h

Outcome

Expired: not evaluated within 7 days of its 24h timeframe elapsing

Evidence

Source Technical analysis pipeline

Claim Neutral reading on OGN

Affected assets OGN

AI inference Neutral · 30%

Reference price 11.26

Verification window 24h

Actual outcome Expired: not evaluated within 7 days of its 24h timeframe elapsing

Provenance

Provider
Rule-Based Analysis

Model version

Not recorded for this call

Methodology version

Scored before versions were recorded

Record

rule-based-analysis #281128
Rule-Based Analysis Excluded from scoring Aug 22, 2026 15:01

Direction
Neutral

Confidence
30%

Reference price
11.26

Verification window
24h

Outcome

Expired: not evaluated within 7 days of its 24h timeframe elapsing

Evidence

Source Technical analysis pipeline

Claim Neutral reading on OGN

Affected assets OGN

AI inference Neutral · 30%

Reference price 11.26

Verification window 24h

Actual outcome Expired: not evaluated within 7 days of its 24h timeframe elapsing

Provenance

Provider
Rule-Based Analysis

Model version

Not recorded for this call

Methodology version

Scored before versions were recorded

Record

rule-based-analysis #278043
Rule-Based Analysis Excluded from scoring Aug 18, 2026 18:16

Direction
Neutral

Confidence
30%

Reference price
11.26

Verification window
24h

Outcome

Expired: not evaluated within 7 days of its 24h timeframe elapsing

Evidence

Source Technical analysis pipeline

Claim Neutral reading on OGN

Affected assets OGN

AI inference Neutral · 30%

Reference price 11.26

Verification window 24h

Actual outcome Expired: not evaluated within 7 days of its 24h timeframe elapsing

Provenance

Provider
Rule-Based Analysis

Model version

Not recorded for this call

Methodology version

Scored before versions were recorded

Record

rule-based-analysis #267872
Rule-Based Analysis Excluded from scoring Aug 16, 2026 12:36

Direction
Neutral

Confidence
30%

Reference price
11.26

Verification window
24h

Outcome

Expired: not evaluated within 7 days of its 24h timeframe elapsing

Evidence

Source Technical analysis pipeline

Claim Neutral reading on OGN

Affected assets OGN

AI inference Neutral · 30%

Reference price 11.26

Verification window 24h

Actual outcome Expired: not evaluated within 7 days of its 24h timeframe elapsing

Provenance

Provider
Rule-Based Analysis

Model version

Not recorded for this call

Methodology version

Scored before versions were recorded

Record

rule-based-analysis #261676
Rule-Based Analysis Excluded from scoring Aug 13, 2026 10:08

Direction
Neutral

Confidence
30%

Reference price
11.26

Verification window
24h

Outcome

Expired: not evaluated within 7 days of its 24h timeframe elapsing

Evidence

Source Technical analysis pipeline

Claim Neutral reading on OGN

Affected assets OGN

AI inference Neutral · 30%

Reference price 11.26

Verification window 24h

Actual outcome Expired: not evaluated within 7 days of its 24h timeframe elapsing

Provenance

Provider
Rule-Based Analysis

Model version

Not recorded for this call

Methodology version

Scored before versions were recorded

Record

rule-based-analysis #255137
Rule-Based Analysis Excluded from scoring Aug 13, 2026 07:08

Direction
Neutral

Confidence
30%

Reference price
11.26

Verification window
24h

Outcome

Expired: not evaluated within 7 days of its 24h timeframe elapsing

Evidence

Source Technical analysis pipeline

Claim Neutral reading on OGN

Affected assets OGN

AI inference Neutral · 30%

Reference price 11.26

Verification window 24h

Actual outcome Expired: not evaluated within 7 days of its 24h timeframe elapsing

Provenance

Provider
Rule-Based Analysis

Model version

Not recorded for this call

Methodology version

Scored before versions were recorded

Record

rule-based-analysis #254958

Prediction history

62 calls logged on OGN, newest first. Nothing is filtered out.

Logged model predictions for OGN
Logged	Provider	Direction	Confidence	Reference price	Evaluated price	Lifecycle	Outcome
Aug 28, 2026 09:17	Rule-Based Analysis	Neutral	30%	11.26	—	Awaiting evaluation	Pending
Aug 27, 2026 06:27	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	No price movement recorded for OGN in the 2 days after its timeframe closed; the symbol appears to have no active price feed
Aug 23, 2026 21:23	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Aug 22, 2026 15:01	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Aug 18, 2026 18:16	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Aug 16, 2026 12:36	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Aug 13, 2026 10:08	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Aug 13, 2026 07:08	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Aug 11, 2026 03:16	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Aug 2, 2026 03:28	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Aug 2, 2026 02:46	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 31, 2026 21:39	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 30, 2026 16:24	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 29, 2026 11:37	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 22, 2026 04:10	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 19, 2026 17:09	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 16, 2026 15:01	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 15, 2026 08:34	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 14, 2026 17:09	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 14, 2026 16:43	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 14, 2026 08:43	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 14, 2026 06:57	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 13, 2026 12:03	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 12, 2026 08:39	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 9, 2026 16:07	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 7, 2026 00:12	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 6, 2026 12:56	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 6, 2026 06:36	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 3, 2026 16:14	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jul 1, 2026 04:30	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 29, 2026 07:01	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 28, 2026 16:45	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 26, 2026 23:16	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 25, 2026 22:54	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 24, 2026 08:10	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 23, 2026 08:43	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 20, 2026 19:14	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 18, 2026 05:10	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 18, 2026 03:44	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 14, 2026 07:03	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 14, 2026 06:41	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 12, 2026 10:59	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 11, 2026 20:06	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
Jun 6, 2026 19:06	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
May 31, 2026 15:54	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
May 30, 2026 08:26	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
May 29, 2026 23:07	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
May 21, 2026 20:50	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
May 20, 2026 10:41	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing
May 15, 2026 06:57	Rule-Based Analysis	Neutral	30%	11.26	—	Excluded from scoring	Expired: not evaluated within 7 days of its 24h timeframe elapsing

Neutral

AI Summary

Confidence

AI Model Multi-Provider AI Analysis

Open article

OGN Stock

OGN at a glance

Dominant narrative

Model agreement

Verification state

Observed bias

Supporting evidence

Calls on this asset

Price Chart

Detailed Market Analysis

Key Levels

Volume & Momentum

Technical Context

Market Sentiment

Stock Metrics

Asset Intelligence Dossier

Provider track record

Confidence trend

What sources say

Insider Trading

Technical Observations

OGN News Intelligence (2 articles)

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

AI evidence

Prediction history

AI Analysis

AI Summary

Market Context